Device entrapment during percutaneous coronary intervention.

PCI complications coronary artery disease percutaneous coronary intervention

Journal

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
ISSN: 1522-726X
Titre abrégé: Catheter Cardiovasc Interv
Pays: United States
ID NLM: 100884139

Informations de publication

Date de publication:
05 2022
Historique:
revised: 20 01 2022
received: 08 11 2021
accepted: 05 03 2022
pubmed: 22 3 2022
medline: 18 5 2022
entrez: 21 3 2022
Statut: ppublish

Résumé

Device entrapment is a life-threatening complication during percutaneous coronary intervention (PCI). However, the success for its management is predominantly based on operator experience with limited available guidance in the published literature. A systematic review was performed on December 2021; we searched PubMed for articles on device entrapment during PCI. In addition, backward snowballing (i.e., review of references from identified articles and pertinent reviews) was employed. A total of 4209 articles were retrieved, of which 150 studies were included in the synthesis of the data. A methodical algorithmic approach to prevention and management of device entrapment can help to optimize outcomes. The recommended sequence of steps are as follows: (a) pulling, (b) trapping, (c) snaring, (d) plaque modification, (e) telescoping, and (f) surgery. In-depth knowledge of the techniques and necessary tools can help optimize the likelihood of successful equipment retrieval and minimization of complications.

Identifiants

pubmed: 35312151
doi: 10.1002/ccd.30160
pmc: PMC9544850
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1766-1777

Informations de copyright

© 2022 The Authors. Catheterization and Cardiovascular Interventions published by Wiley Periodicals LLC.

Références

Cardiovasc Revasc Med. 2021 Jul;28S:140-143
pubmed: 33046415
Hellenic J Cardiol. 2011 Jan-Feb;52(1):79-83
pubmed: 21292611
Cardiovasc Interv Ther. 2021 Jan;36(1):1-18
pubmed: 33079355
Catheter Cardiovasc Interv. 2022 May;99(6):1766-1777
pubmed: 35312151
Catheter Cardiovasc Interv. 2000 Jan;49(1):82-4; discussion 85
pubmed: 10627374
Catheter Cardiovasc Interv. 2003 Aug;59(4):463-5
pubmed: 12891607
Catheter Cardiovasc Interv. 2010 Feb 15;75(3):351-3
pubmed: 19806638
Catheter Cardiovasc Interv. 2016 Mar;87(4):749-56
pubmed: 26651133
JACC Cardiovasc Interv. 2017 Dec 26;10(24):e227-e229
pubmed: 29153503
Curr Cardiol Rev. 2013 Aug;9(3):260-6
pubmed: 23116055
Hellenic J Cardiol. 2017 May - Jun;58(3):236-238
pubmed: 28455008
JACC Cardiovasc Interv. 2013 Feb;6(2):128-36
pubmed: 23352817
Catheter Cardiovasc Interv. 2011 Jan 1;77(1):58-61
pubmed: 20506291
World J Cardiol. 2019 Jul 26;11(7):189-194
pubmed: 31565194
Catheter Cardiovasc Interv. 2012 Feb 1;79(2):271-3
pubmed: 21793173
Catheter Cardiovasc Interv. 2014 Nov 1;84(5):750-6
pubmed: 24478270
Cardiovasc Revasc Med. 2019 Nov;20(11):1023-1026
pubmed: 30497930
J Cardiol Cases. 2019 Aug 22;20(5):168-171
pubmed: 31719937
J Invasive Cardiol. 2012 May;24(5):215-21
pubmed: 22562915
Indian Heart J. 2018 Dec;70 Suppl 3:S446-S455
pubmed: 30595306
Int J Cardiol. 2016 Mar 15;207:1-2
pubmed: 26784563
Catheter Cardiovasc Interv. 2000 Dec;51(4):483-6
pubmed: 11108687
Catheter Cardiovasc Interv. 2017 Nov 1;90(5):773-776
pubmed: 28766865
Cardiovasc Interv Ther. 2016 Jan;31(1):70-4
pubmed: 25708708
Acta Cardiol Sin. 2017 Jan;33(1):96-98
pubmed: 28115813
EuroIntervention. 2021 Jun 25;17(3):212-219
pubmed: 32894229
EuroIntervention. 2021 Aug 06;17(5):e436-e438
pubmed: 32624461
Catheter Cardiovasc Interv. 2020 Sep 1;96(3):601-608
pubmed: 31797536
J Clin Diagn Res. 2015 Oct;9(10):OD01-3
pubmed: 26557557
Cardiovasc Revasc Med. 2022 Mar;36:132-135
pubmed: 33958304
Cardiovasc Interv Ther. 2015 Jan;30(1):57-60
pubmed: 24532231
Cardiovasc Revasc Med. 2021 Jul;28S:208-211
pubmed: 33397603
EuroIntervention. 2013 Jun 22;9(2):251-8
pubmed: 23793010
Cardiovasc Revasc Med. 2016 Jun;17(4):282-6
pubmed: 27106743
Cardiovasc Revasc Med. 2021 Jul;28S:136-139
pubmed: 33168432
J Invasive Cardiol. 2017 May;29(5):E61-E62
pubmed: 28441644
Cardiovasc Revasc Med. 2016 Mar;17(2):129-33
pubmed: 26826011

Auteurs

Jorge Sanz-Sánchez (J)

Interventional cardiology Unit, Hospital Universitari i Politecnic La Fe, Valencia, Spain.
Centro de Investigación Biomedica en Red (CIBERCV)-Madrid, Madrid, Spain.

Kambis Mashayekhi (K)

Division of Cardiology, University Heart Center Freiburg-Bad Krozingen, Bad Krozingen, Germany.

Pierfrancesco Agostoni (P)

Hartcentrum, Ziekenhuis Netwerk Antwerpen (ZNA) Middelheim, Antwerpen, Belgium.

Mohaned Egred (M)

Department of Cardiology, Freeman Hospital, Newcastle upon Tyne, UK.
Division of Cardiology, School of Medicine, University of Sunderland, Sunderland, UK.
Division of Cardiology, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.

Alexandre Avran (A)

Department of Interventional Cardiology, Clinique Pasteur, Essey-lès-Nancy, France.

Arun Kalyanasundaram (A)

Interventional Cardiology Unit, Division of Cardiology, Promed Hospital, Chennai, India.

Roberto Garbo (R)

Department of Interventional Cardiology, Maria Pia Hospital, Torino, Italy.

Antonio Colombo (A)

Interventional Cardiology Unit, IRCCS Humanitas Clinical and Research Center, Milan, Italy.

Damiano Regazzoli (D)

Interventional Cardiology Unit, IRCCS Humanitas Clinical and Research Center, Milan, Italy.

Bernhard Reimers (B)

Interventional Cardiology Unit, IRCCS Humanitas Clinical and Research Center, Milan, Italy.

Emmanouil S Brilakis (ES)

Interventional Cardiology Unit, Minneapolis Heart Institute, Minneapolis, Minnesota, USA.

Gabriele L Gasparini (GL)

Interventional Cardiology Unit, IRCCS Humanitas Clinical and Research Center, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH